You are here

Joseph Kitzmiller

  • 333 W Tenth Avenue
    5086 Graves Hall
    Columbus, OH 43210


  • September, 2011-
    July, 2016

    Clinical and Translational Scholar Award in Pharmacogenomics and Personalized Medicine.

  • March, 2015

    Faculty Acheivement Award in Research.

  • June, 2014

    Faculty Research Award in Integrative Health and Wellness.

  • August, 2011

    Young Investigator Award.

Journal Articles


  • Kitzmiller, J.P.; Mikulik, E.B.; Dauki, A.M.; Murkherjee, C. et al., 2016, "Pharmacogenomics of statins: Understanding susceptibility to adverse effects." Pharmacogenomics and Personalized Medicine 9, 97-106 - 97-106.
  • Sardo, C.L.; Kitzmiller, J.P.; Apseloff, G.; Harris, R.B. et al., 2016, "An Open-Label Randomized Crossover Trial of Lyophilized Black Raspberries on Postprandial Inflammation in Older Overweight Males: A Pilot Study." American Journal of Therapeutics 23, no. 1, e86-e91 - e86-e91.


  • Kitzmiller, J.P.; Barnett, C.J.; Steiner, N.S.; Stoicea, N. et al., 2015, "Buprenorphine: Revisiting the efficacy of transdermal delivery system." Therapeutic Delivery 6, no. 4, 419-422 - 419-422.
  • Kitzmiller, J.P.; Luzum, J.A.; Isackson, P.J.; Ma, C. et al., 2015, "GATM Polymorphism Associated with the Risk for Statin-Induced Myopathy Does Not Replicate in Case-Control Analysis of 715 Dyslipidemic Individuals." CELL METABOLISM 21, no. 4,
  • Kitzmiller,Joseph,P; Barnett,Christopher,J; Steiner,Nathan,S; Stoicea,Nicoleta; Kamar,Nawal; Luzum,Jasmine,A; Mikulik,Eduard; Bergese,Sergio,D, 2015, "Buprenorphine: revisiting the efficacy of transdermal delivery system.." THERAPEUTIC DELIVERY 6, no. 4, 419-422 - 419-422.
  • Wang,Jiang; Luzum,Jasmine,A; Phelps,Mitch,A; Kitzmiller,Joseph,P, 2015, "Liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of simvastatin, lovastatin, atorvastatin, and their major metabolites in human plasma." JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 983, 18-25 - 18-25.
  • Luzum, J.A.; Theusch, E.; Taylor, K.D.; Wang, A. et al., 2015, "Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations." Journal of Cardiovascular Pharmacology 66, no. 1, 80-85 - 80-85.


  • Kitzmiller,Joseph,P; Phelps,Mitch,A; Neidecker,Marjorie,V; Apseloff,Glen, 2014, "Establishing a clinical pharmacology fellowship program for physicians, pharmacists, and pharmacologists: a newly accredited interdisciplinary training program at the Ohio State University.." ADVANCES IN MEDICAL EDUCATION AND PRACTICE 5, 191-196 - 191-196.
  • George M, Korbel L, Haasz M, Coronado A, Kitzmiller JP, 2014, "Managing Acute Asthma Exacerbations in Pediatric Patients: Should Peak Flow Measurements (PFM) or Pediatric Respiratory Assessment Measure (PRAM) Scores be used to Titrate Bronchodialtor Treatment?." ANN PEDIATR CHILD HEALTH 2, no. 2, 1015-1018 - 1015-1018.
  • Talameh, J.A.; Kitzmiller, J.P., 2014, "Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic Variants.." J Pharmacogenomics Pharmacoproteomics 5, no. 2,
  • Kitzmiller, J.P.; Luzum, J.A.; Baldassarre, D.; Krauss, R.M. et al., 2014, "CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.." Pharmacogenet Genomics 24, no. 10, 486-491 - 486-491.
  • Kitzmiller, J.P.; Phelps, M.A.; Neidecker, M.V.; Apseloff, G., 2014, "Establishing a clinical pharmacology fellowship program for physicians, pharmacists, and pharmacologists: a newly accredited interdisciplinary training program at the Ohio State University.." Adv Med Educ Pract 5, 191-196 - 191-196.
  • Korbel, L.; George, M.; Kitzmiller, J., 2014, "Clinically relevant pharmacogenomic testing in pediatric practice.." Clin Pediatr (Phila) 53, no. 9, 831-838 - 831-838.


  • Kitzmiller, J.P.; Sullivan, D.M.; Phelps, M.A.; Wang, D. et al., 2013, "CYP3A4/5 combined genotype analysis for predicting statin dose requirement for optimal lipid control." Drug Metabolism and Drug Interactions 28, no. 1, 59-63 - 59-63.
  • George, M.; Haasz, M.; Coronado, A.; Salhanick, S. et al., 2013, "Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: A case study." BMC Pediatrics 13, no. 1,
  • Kitzmiller, J.P.; Foraker, R.E.; Rose, K.M., 2013, "Lipid-lowering pharmacotherapy and socioeconomic status: Atherosclerosis risk in communities (ARIC) surveillance study." BMC Public Health 13, no. 1,
  • Apseloff, G.; Kitzmiller, J.P.; Tishler, C.L., 2013, "Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies." American Journal of Therapeutics 20, no. 3, 257-260 - 257-260.
  • Baldassarre, D.; Amato, M.; Frigerio, B.; Columbo, G. et al., 2013, "[Pharmacogenomic Biomarkers for the Prediction of Statin Efficacy and Safety].." G Ital Arterioscler 4, no. 4, 23-35 - 23-35.
  • Kitzmiller,Joseph,P; Binkley,Philip,F; Pandey,Saurabh,R; Suhy,Adam,M; Baldassarre,Damiano; Hartmann,Katherine, 2013, "Statin Pharmacogenomics: Pursuing Biomarkers for Predicting Clinical Outcomes." DISCOVERY MEDICINE 86, 45-51 - 45-51.
  • Kapil, R.P.; Cipriano, A.; Friedman, K.; Michels, G. et al., 2013, "Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels." Journal of Pain and Symptom Management 46, no. 1, 65-75 - 65-75.


  • Kitzmiller, J.P.; Embi, P.J.; Manickam, K.; Sweet, K.M. et al., 2012, "Institutional profile: Program in pharmacogenomics at the ohio state university medical Center." Pharmacogenomics 13, no. 7, 751-756 - 751-756.
  • George, M.; Phelps, M.A.; Kitzmiller, J.P., 2012, "Acetaminophen pediatric dose selection: Caregiver satisfaction regarding the antipyretic efficacy of acetaminophen in children." Clinical Pediatrics 51, no. 11, 1030-1031 - 1030-1031.
  • George, M.; Kitzmiller, J.P.; Ewald, M.B.; O'Donell, K.A. et al., 2012, "Methadone Toxicity and Possible Induction and Enhanced Elimination in a Premature Neonate." Journal of Medical Toxicology 8, no. 4, 432-435 - 432-435.


  • Kitzmiller, J.P.; Groen, D.K.; Phelps, M.A.; Sadee, W., 2011, "Pharmacogenomic testing: Relevance in medical practice: Why drugs work in some patients but not in others." Cleveland Clinic Journal of Medicine 78, no. 4, 243-257 - 243-257.


  • Kitzmiller, J.P.; Groen, D.K.; Ardeleanu, M.; Apseloff, G., 2010, "A novel minimally-invasive method for eliciting incisional pain in healthy adults." Journal of Anaesthesiology Clinical Pharmacology 26, no. 1, 54-58 - 54-58.


  • Kitzmiller, J.P.; Groen, D.K.; Apseloff, G., 2009, "PI-34: An Analysis of Subjects in Clinical Trials Who, After Dosing, Report Predose Adverse Events and Abnormalities in Their Medical Histories (vol 85, pg S9, 2009)." CLINICAL PHARMACOLOGY & THERAPEUTICS 85, no. 5, 558-558 - 558-558.


  • Kitzmiller, J.P.; Hansford, D.J.; Fortin, L.D.; Obrietan, K.H. et al., 2007, "Micro-field evoked potentials recorded from the porcine sub-dural cortical surface utilizing a microelectrode array." Journal of Neuroscience Methods 162, no. 1-2, 155-161 - 155-161.


  • Kitzmiller,J; Beversdorf,D; Hansford,D, 2006, "Fabrication and testing of microelectrodes for small-field cortical surface recordings." BIOMEDICAL MICRODEVICES 8, no. 1, 81-85 - 81-85.


  • "Translational Pharmacogenomics in Cardiovascular Medicine." 2014, Presented at Millenium Health Research Institute,
  • "Evidence-based Medicine Approach to Plant-based Nutrition and Therapies." 2016, Presented at 20th Clinical Applications for Age Management Medicine,
  • "Personalized Medicine and Pharmacogenomics." 2012, Presented at American Association of Pharmaceutical Scientists,
  • "Developing A Multigenic Risk-score Model for Simvastatin-induced Myopathy." 2015, Presented at The NIH Pharmacogenomics Research Network National Meeting,
  • "Cardiovascular Pharmacogenomics." 2015, Presented at 19th Clinical Applications for Age Management Medicine,
  • "The Gnome Cardiac Health Panel: Potential Benefits for Residents of Long-term Care Facilities." 2015, Presented at OmniCare Health,

Papers in Proceedings


  • George M, Mucha S, Kitzmiller JP, Weaver D "Comparison of Pediatric Asthma Clinical Trials Pre- and Post-EPR-3." in Proceedings of 2015 Pediatric Academic Society Annual Meeting. (8 2015).


  • Kitzmiller JP, Neidecker MV, Mikulik E, Apseloff G "A Developing Registry of Cardiac Clinical Findings (ECG and Holter-monitor parameters) in Early-phase Clinical Trials." in Proceedings of 4th International Conference on Clinical and Experimental Cardiology. (8 2014).